A

Autolus Therapeutics plc

AUTL

4.52000
USD
-0.17
(-3.62%)
Market Closed
Volume
68,143
EPS
0
Div Yield
0
P/E
-3
Market Cap
933,991,544
News

Title: Autolus Therapeutics plc

Sector: Healthcare
Industry: Biotechnology
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3,AUTO5, AUTO6, AUTO7 & AUTO8.